Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 71,873,880
- Share change
- +2,015,902
- Total reported value
- $807,766,000
- Price per share
- $11.26
- Number of holders
- 46
- Value change
- +$18,577,946
- Number of buys
- 29
- Number of sells
- 15
Report period
Q4 2021
Institutions
46
Top holders
10
CNTA full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
|
Company |
12%
|
17,923,892
|
$299,329,000 | — | 30 Sep 2021 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
6.3%
|
9,681,818
|
$161,686,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
5,607,302
|
$91,362,000 | — | 30 Sep 2021 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
2.6%
|
3,931,818
|
$65,661 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.3%
|
3,577,094
|
$59,737,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
2,017,873
|
$33,091,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
1,727,273
|
$28,724,000 | — | 30 Sep 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1%
|
1,537,533
|
$25,677,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.87%
|
1,334,227
|
$22,282,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.73%
|
1,127,273
|
$18,825,000 | — | 30 Sep 2021 | |
| Venrock Adviser, LLC |
13F
|
Company |
0.73%
|
1,127,272
|
$18,825,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.69%
|
1,069,545
|
$17,861,000 | — | 30 Sep 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
1,018,800
|
$17,014,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.6%
|
922,100
|
$15,399,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.57%
|
882,813
|
$14,743,000 | — | 30 Sep 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.49%
|
754,545
|
$12,601,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.24%
|
370,292
|
$6,184,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.24%
|
362,737
|
$6,058,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.23%
|
349,548
|
$5,837,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
337,002
|
$5,628,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.2%
|
302,200
|
$5,047,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.19%
|
296,456
|
$4,951,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.19%
|
286,404
|
$4,783,000 | — | 30 Sep 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.13%
|
203,183
|
$3,393,000 | — | 30 Sep 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.04%
|
62,500
|
$1,044,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
33,252
|
$555,000 | — | 30 Sep 2021 | |
| BROOKFIELD Corp /ON/ |
13F
|
Company |
0.02%
|
26,788
|
$447,000 | — | 30 Sep 2021 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.01%
|
15,000
|
$251,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
12,420
|
$207,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
7,630
|
$128,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,771
|
$46,000 | — | 30 Sep 2021 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0%
|
2,750
|
$46,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,828
|
$30,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
453
|
$8,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
221
|
$4,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
209
|
$3,000 | — | 30 Sep 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
200
|
$3,000 | — | 30 Sep 2021 | |
| Evolution Wealth Advisors, LLC |
13F
|
Company |
0%
|
160
|
$3,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
119
|
$2,000 | — | 30 Sep 2021 | |
| INDEX VENTURES LIFE VI (JERSEY) L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
149,421
|
$1,189,391 | — | 27 May 2021 | |
| Aaron Kantoff |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
$477,600 | — | 18 Nov 2021 |
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) as of Q4 2021
As of 31 Dec 2021,
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,873,880 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, Index Venture Life Associates VI Ltd, GENERAL ATLANTIC, L.P., JANUS HENDERSON GROUP PLC, Vida Ventures Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, OUP Management Co., LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Samsara BioCapital, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
38
Q4 2021 holders
46
Holder diff
8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.